Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
J Perinat Med ; 47(9): 986-990, 2019 Nov 26.
Article in English | MEDLINE | ID: mdl-31586967

ABSTRACT

Objective To describe the clinical characteristics and risk factors in infants with subcutaneous fat necrosis (SFN) following therapeutic hypothermia for hypoxic-ischemic encephalopathy (HIE). Methods A case-control study was performed by a retrospective chart review of infants with moderate or severe HIE admitted to a level IV regional perinatal center and who underwent whole-body cooling. Results A total of 14 (8.1%) of 171 infants with moderate or severe HIE who underwent whole-body cooling developed SFN during hospitalization. There were more females [71% (10/14)] and large-for-gestational age (LGA) infants [28% (4/14)] in the SFN group vs. 36% females (57/157) and 8% LGA infants (13/157) in the group without SFN (P-values of 0.009 and 0.015, respectively). The mean lowest platelet count was lower 108 ± 55 109/L vs. 146 ± 62 109/L and the mean highest calcium level was higher 11.3 ± 2.5 vs. 10.6 ± 0.8 mg/dL in infants with SFN vs. infants without SFN, respectively (P-values of 0.0078 and 0.006, respectively). Distribution of skin lesions followed distinctive patterns representing the areas with direct contact with the cooling blanket. One infant developed severe, life-threatening hypercalcemia that required aggressive management, including diuretics, corticosteroids and bisphosphonates. Conclusion Although SFN is a rare complication of therapeutic hypothermia, it can be a life-threatening condition if complicated by severe hypercalcemia. Infants who undergo therapeutic hypothermia for HIE need regular skin examinations to evaluate for SFN. If SFN is identified, monitoring of serum calcium levels to prevent life-threatening hypercalcemia is recommended.


Subject(s)
Fat Necrosis/etiology , Hypothermia, Induced/adverse effects , Hypoxia-Ischemia, Brain/therapy , Subcutaneous Fat/pathology , Case-Control Studies , Fat Necrosis/diagnosis , Fat Necrosis/pathology , Female , Humans , Hypoxia-Ischemia, Brain/complications , Infant, Newborn , Male , Retrospective Studies , Risk Factors
3.
Glob Pediatr Health ; 6: 2333794X19857415, 2019.
Article in English | MEDLINE | ID: mdl-31259210

ABSTRACT

There is variability in practice among care providers on feeding infants admitted with neonatal hypoglycemia (NH) for parenteral dextrose. We compared clinical outcomes in infants who were fed (NH-Fed) and hypoglycemic infants who were kept nothing per os (NPO) (NH-NPO) at the time of initiation of intravenous (IV) dextrose. We performed a retrospective review of all newborn infants admitted to the neonatal intensive care unit with NH for IV dextrose. Infants were grouped as per the feeding approach at initiation of IV dextrose: NH-Fed or NH-NPO infants. We found that infants in the NH-Fed group had lower maximum glucose infusion rate, less duration of glucose infusion therapy compared with the NH-NPO group, and significantly less number of days of hospital stay compared with the NH-NPO group (5.87 ± 1.4 days vs 4.9 ± 1.4 days, P < .006). In conclusion, feeding infants with hypoglycemia who require IV dextrose offers tangible benefits of shorter duration of parenteral dextrose and shorter length of hospitalization.

5.
BMJ Case Rep ; 20162016 Aug 17.
Article in English | MEDLINE | ID: mdl-27535729

ABSTRACT

Isolated ACTH deficiency (IAD) is a rare cause of neonatal cholestasis and hypoglycaemia. This diagnosis has a 20% mortality potential if unrecognised. We describe a case of an infant presenting with cholestatic jaundice and hypoglycaemia. The patient had laboratory findings suggestive of IAD, which was later confirmed with molecular genetic testing. One of the mutations this patient had is a new finding. The patient was started on glucocorticoid replacement therapy after which his bilirubin and glucose levels normalised.


Subject(s)
Adrenocorticotropic Hormone/deficiency , Endocrine System Diseases/complications , Genetic Diseases, Inborn/complications , Hypoglycemia/complications , Jaundice, Obstructive/etiology , Adrenal Cortex Hormones/administration & dosage , Adrenocorticotropic Hormone/genetics , Diagnosis, Differential , Endocrine System Diseases/genetics , Genetic Diseases, Inborn/genetics , Homeodomain Proteins/genetics , Humans , Hydrocortisone/administration & dosage , Hypoglycemia/etiology , Hypoglycemia/genetics , Infant, Newborn , Male , Mutation/genetics , T-Box Domain Proteins/genetics , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...